Congratulations to Dr. Menegatti and Dr. Carbonell for receiving $60,000 from the Chancellor’s Innovation Fund. This fund will go towards the development and commercialization of a novel technology for purification of therapeutic monoclonal antibodies. The initial work is summed in these two articles: “Targeted Capture of Chinese Hamster Ovary Host Cell Proteins: Peptide Ligand Discovery” and “Targeted capture of Chinese hamster ovary host cell proteins: Peptide ligand binding by proteomic analysis.”